Skip to main contentAI and Advanced
/
TTKHLTCARE · NSEBSE SENSEX74,336.45+0.45%BSE |
NIFTY 5023,217.6+0.43%NSE |
NIFTY BANK56,292.45+0.89%NSE |
NIFTY IT29,087.65-1.58%NSE |
NIFTY AUTO26,893.65+0.51%NSE |
NIFTY FMCG45,559+1.63%NSE |
NIFTY PHARMA26,146.2-0.16%NSE |
NIFTY 50022,532+0.24%NSE |
TT
NSE · Equity shares · Biotechnology & Drugs-13.60 · -1.27%
TTK Healthcare TTKHLTCARE
NSE:INR 1,061
BSE:INR 1,068
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for TTKHLTCARE
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 1,074.6
Day rangeINR 1,059 — INR 1,082.9
52-week rangeINR 735 — INR 1,359.1
Volume18,487
Market cap1,464.75
P/E15.91
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)857.28
Net Income (INR Cr)65.68
Rev Growth (5 Year %)12.48
EPS Growth (5 Year %)12.3
P/E Ratio15.91
Book Value788.98
EPS48.78
Price/BV1.34Computed
Research path: Interpret TTK Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
TTKHLTCARETTK Healthcare1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 1,328.74 | 1,281.19 | 1,206.3 |
| Accumulated Depreciation Total | -108.17 | -101.73 | -102.23 |
| Cash Equivalents | 9.96 | 0 | 3.25 |
| Other Liabilities Total | 5.68 | 3.44 | 3.06 |
| Accrued Expenses | 35.24 | 30.36 | 30.65 |
| Common Stock Total | 14.13 | 14.13 | 14.13 |
| Other Equity Total | 7.94 | 10.74 | 12.12 |
| Other Current Assets Total | 1.23 | 1.2 | 2.79 |
| Prepaid Expenses | 3.13 | 3.1 | 2.7 |
| Total Assets | 1,328.74 | 1,281.19 | 1,206.3 |
| Current Portof LT Debt/Capital Leases | 0.49 | 0.51 | 0.54 |
| Additional Paid-In Capital | 9.82 | 9.82 | 9.82 |
| Cash | 11.93 | 9.01 | 7.71 |
| Total Equity | 1,114.85 | 1,065.05 | 1,000.92 |
| Long Term Investments | 19.42 | 78.12 | 35.65 |
| Retained Earnings(Accumulated Deficit) | 1,078.54 | 1,025.94 | 960.42 |
| Total Common Shares Outstanding | 1.41 | 1.41 | 1.41 |
| Property/Plant/Equipment Total-Gross | 182.21 | 182.71 | 177.82 |
| Tangible Book Valueper Share Common Eq | 788.98 | 753.73 | 708.34 |
| Total Liabilities | 213.89 | 216.14 | 205.38 |
| Total Debt | 24.38 | 24.22 | 22.81 |
| Short Term Investments | 914.36 | 846.11 | 834.25 |
| Cashand Short Term Investments | 936.24 | 855.12 | 845.21 |
| Total Receivables Net | 161.86 | 130.47 | 126.97 |
| Notes Payable/Short Term Debt | 21.9 | 21.94 | 21.47 |
| Accounts Receivable-Trade Net | 143.66 | 121.8 | 113.51 |
| Property/Plant/Equipment Total-Net | 74.04 | 80.98 | 75.59 |
| Total Current Liabilities | 206.23 | 210.92 | 201.52 |
| Total Inventory | 115.44 | 114.01 | 99.63 |
| Accounts Payable | 91.3 | 106.84 | 102.26 |
| Other Currentliabilities Total | 57.29 | 51.27 | 46.59 |
| Total Long Term Debt | 1.98 | 1.77 | 0.8 |
| Intangibles Net | 0 | 0 | 0.01 |
| Other Long Term Assets Total | 9.46 | 9.16 | 8.31 |
| Note Receivable-Long Term | 7.93 | 9.04 | 9.44 |
| Unrealized Gain(Loss) | 4.41 | 4.41 | 4.41 |
| Total Current Assets | 1,217.9 | 1,103.89 | 1,077.3 |
| Capital Lease Obligations | 1.98 | 1.77 | 0.8 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio1.61
Price to Sale Ratio1.71
Growth
Debt 5Yr CAGR %4.95
Margins
Operating Margin 12m1.56
Operating Margin 5y Avg2.11
Net Profit Margin 12m7.66
Net Profit Margin 5y7.32
Yield
Dividend Yield %0.97
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk30.15
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,937.3 | 4.65 L | 38.4 | — |
| Divi's Laboratories | INR 7,375 | 1.96 L | 73.32 | — |
| Torrent Pharmaceuticals | INR 4,981 | 1.69 L | 72.73 | — |
| Cipla | INR 1,405.65 | 1.14 L | 27.57 | — |
| Zydus Lifesciences | INR 1,118 | 1.11 L | 21.19 | — |
Shareholding
Ownership
- Promoter
- 74.56%
- MF
- 0.04%
- Other
- 25.44%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
TTK Healthcare Ltd. is Rated Sell by MarketsMOJO - MarketsMojoMarket news · 21 Jul 2026, 2:48 am
TTK Healthcare Ltd. is Rated Sell by MarketsMOJO MarketsMojo
TTK Healthcare Files SEBI Compliance Certificate for June Quarter - TipRanksMarket news · 3 Jul 2026, 6:42 pm
TTK Healthcare Files SEBI Compliance Certificate for June Quarter TipRanks
TTK Healthcare FY26 Annual Report: Revenue Up ~7%, Profit Hit by PDD Headwinds - scanx.tradeMarket news · 27 Jun 2026, 5:34 pm
TTK Healthcare FY26 Annual Report: Revenue Up ~7%, Profit Hit by PDD Headwinds scanx.trade
TTK Healthcare reports sustainability performance for FY26 - scanx.tradeMarket news · 27 Jun 2026, 3:07 pm
TTK Healthcare reports sustainability performance for FY26 scanx.trade
TTK Healthcare FY26 Revenue Up, Profit Declines Amidst Segment Challenges - WhalesbookMarket news · 27 Jun 2026, 2:43 pm
TTK Healthcare FY26 Revenue Up, Profit Declines Amidst Segment Challenges Whalesbook
Enterprise value to revenue forward of TTK Healthcare Limited – NSE:TTKHLTCARE - TradingViewMarket news · 27 Jun 2026, 7:53 am
Enterprise value to revenue forward of TTK Healthcare Limited – NSE:TTKHLTCARE TradingView
Corporate actions
Events
- annual General MeetingAGM
- dividendRs.10.0000 per share(100%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- annual General Meeting(Revised)
- board MeetingsTo consider other business matters.
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
Rusaka Markets Community
Discussion and sentiment for TTK Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
TTK Healthcare Limited is an India-based company providing consumer and healthcare products. The Company's segments include Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, and Others. The Animal Welfare segment offers products for veterinary use, including the brands Ossomin, Orcal-P, Epidosin, and others. The Consumer Products segment markets and distributes Woodward's Gripe Water, the EVA range of cosmetics, the Good Home range of scrubbers, air fresheners, and various other products. The Medical Devices segment includes the manufacturing and marketing of artificial heart valves, orthopedic implants, and others. The Protective Devices segment focuses on manufacturing and marketing male contraceptives and related products. The Foods segment involves the manufacturing and marketing of food products. Extruded products, such as papads, are offered under the brand name Fryums. The Others segment includes the printing and publishing of maps and atlases.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- TTKHLTCARE
- BSE Code
- 507747
Questions
Stock FAQ
What is the symbol and ISIN of TTK Healthcare?
TTK Healthcare has the symbol TTKHLTCARE and ISIN - INE910C01018.
What is the current price of TTK Healthcare?
TTK Healthcare is currently trading at INR 1,061.00.
What are the year high and year low of TTK Healthcare?
TTK Healthcare has a year high of INR 1,359.10 and a year low of INR 735.00.
What is the market capitalization of TTK Healthcare?
TTK Healthcare has a market capitalization of INR 1,464.75 crore.
What is the P/E ratio of TTK Healthcare?
TTK Healthcare has a P/E ratio of 15.91.
What is the dividend yield of TTK Healthcare?
TTK Healthcare has a dividend yield of 0.97%.
How is the financial performance of TTK Healthcare based on revenue, net income, and EPS?
TTK Healthcare has revenue of INR 857.28 crore, net income of INR 65.68 crore, and EPS of INR 48.66.
What is the book value of TTK Healthcare?
TTK Healthcare has a book value of INR 788.98.
What is the debt-to-equity ratio of TTK Healthcare?
TTK Healthcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of TTK Healthcare?
TTK Healthcare has a price-to-book ratio of 1.34 and a price-to-sales ratio of 1.71.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.